Neisseria Meningitidis Burden of Disease Study

计划入组 521 人 · 首次发布于 2012 年 11 月 21 日

N. Meningitidis Carriage Study

计划入组 1,000 人 · 首次发布于 2013 年 3 月 11 日

Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 in Patients Having to be Vaccinated MenBVac® (Extension EFFIVAC)

计划入组 120 人 · 首次发布于 2012 年 6 月 18 日

Neisseria meningitidis group Y capsular polysaccharide tetanus toxoid conjugate antigen(Menquadfi, Nimenrix)

Ag473 Neisseria meningitidis vaccine (NHRI)

Neisseria meningitidis serogroup b fhbp fusion protein antigen(Bexsero)

FDA Gears Up for Key Decisions on Vaccines and Novel Therapies in H1 2025

EMA Accepts GSK's Submission for Single-Dose Bexsero Booster in Adolescents and Young Adults

GSK's Pipeline Strengthens with Positive Phase III Trials, Anticipates Multiple Product Launches in 2025